UNICEF s Quality Assurance System for procurement of medicines

Size: px
Start display at page:

Download "UNICEF s Quality Assurance System for procurement of medicines"

Transcription

1 UNICEF s Quality Assurance System for procurement of medicines QA Specialist Peter Svarrer Jakobsen Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen 23 September 2014

2 UNICEF QA SYSTEM BASED ON: WRITTEN DOCUMENTATION SYSTEM BASED ON QUALITY MANUAL, DIVISION PROCEDURES AND CENTRE PROCEDURES PRINCIPLES OF THE WHO MODEL QA SYSTEM FOR PROCUREMENT AGENCIES FOLLOWED - TRS 986 ANNEX 3 PRINCIPLES OF PIC-S QUALITY SYSTEM REQUIREMENTS FOR GMP INSPECTORATES FOLLOWED ALL PROCUREMENT ACTIVITIES ARE CENTRALIZED IN UNICEF SUPPLY DIVISION (PROCUREMENT BY UNICEF COUNTRY OFFICES REQUIRES SPECIFIC AUTHORIZATION)

3 PRE-QUALIFICATION - MEDICINES PRODUCTS PRODUCT QUESTIONNAIRE AS IN THE WHO MODEL QA SYSTEM WHO TRS 986 SUPPLIERS REVIEW OF SUBMITTED DOCUMENTATION AND/OR GOOD MANUFACTURING PRACTICE (GMP) INSPECTIONS TO ENSURE COMPLIANCE WITH WHO GMP GUIDELINES

4 PRE-QUALIFICATION OF SUPPLIERS HOW? TECHNICAL QUESTIONNAIRE MANUFACTURING SITE (S) DEFINED DOSAGE FORMS / PRODUCTS OF INTEREST EXPORT EXPERIENCE LICENSE TO MANUFACTURE MEDICINAL PRODUCTS IS A GMP INSPECTION NEEDED?

5 GMP INSPECTIONS DECISION BASED ON THE REGULATORY ENVIRONMENT IN COUNTRY OF ORIGIN AND PRIOR EXPERIENCE OF UNICEF GMP INSPECTION BY UNICEF OR A REPRESENTATIVE SELECTED BY UNICEF CONTRACT MANUFACTURE ONLY ACCEPTED IF SUB- CONTRACTOR ALSO IS APPROVED BY UNICEF

6 GMP INSPECTIONS BY UNICEF TO CHECK COMPLIANCE WITH WHO GMP GUIDELINES 135 GMP INSPECTIONS CARRIED OUT IN COMPANIES FAILED (15%) DETAILED GMP INSPECTION REPORT FORWARDED TO COMPANY WITH REQUEST TO RESPOND WITHIN 1 MONTH ANNUAL INSPECTION PLAN IS ESTABLISHED (FREQUENCY OFTEN 2 5 YEARS)

7 GMP INSPECTIONS COLLABORATION LOCAL AUTHORITY INVITED TO PARTICIPATE JOINT INSPECTIONS WITH WHO PQ, ICRC, MSF UNICEF RELY ON WHO PQ OF VACCINES, HIV, MALARIA AND TB PRODUCTS UNICEF IS A PARTNER TO THE PHARMACEUTICAL INSPECTION COOPERATION SCHEME (PIC-S) UNICEF USE AVAILABLE INFORMATION FROM PARTNERS AND PIC/S MEMBER AUTHORITIES TO WAIVE UNICEF GMP INSPECTIONS COMPANIES THAT ARE FOUND GMP NON-COMPLIANT BY UNICEF PARTNERS SHOULD NOT CONTINUE TO SUPPLY TO UNICEF. INSTANT NOTIFICATION MUST BE PROVIDED

8 UNICEF SUPPLY DIVISION WAREHOUSE LICENSED BY THE DANISH HEALTH AND MEDICINES AGENCY: TO WHOLESALE OF MEDICINES HANDLE NARCOTIC AND PSYCHOTROPIC SUBSTANCES COMPLIANCE WITH EUROPEAN UNION GUIDELINE ON GOOD DISTRIBUTION PRACTICE (GDP) UNICEF WHOLESALE MEDICINES IT IS NOT SUPPLY UNDER A CONTRACT MANUFACTURE AGREEMENT

9 PROBLEMS AT UNICEF GOODS RECEIPT NO PACKING LIST MISSING CERTIFICATE AT GOODS RECEIPT PLEASE NOTE: UPON SHIPMENT OF THE ORDER, THE PACKING LIST AND THE RELEVANT CERTIFICATES OF ANALYSIS SHOULD BE SENT AS SEPARATE PDF FILES VIA TO THE ATTACHED FILES SHOULD NOT EXCEED 6MB UNICEF'S PURCHASE ORDER NUMBER SHOULD BE STATED ON THE SUBJECT LINE OF ALL CORRESPONDENCE. FAILURE TO COMPLY WITH THIS PROCEDURE MAY RESULT IN PAYMENT DELAYS.

10 PROBLEMS AT UNICEF GOODS RECEIPT SUB-HEADER ARIAL 18 LOOSE LABELS ON PRIMARY PACKS (TABLET CONTAINERS) NO LEAFLET OR LEAFLET NOT PACKED TOGETHER WITH THE PRIMARY PACK CERTIFICATE OF ANALYSIS DO NOT INCLUDE NAME OF MANUFACTURING SITE TO LITTLE REMAINING SHELF LIFE (OBTAIN PRIOR APPROVAL IF NEEDED FROM STAFF WHO PLACED THE ORDER)

11 UNICEF QUALITY CONTROL TESTING ANALYSIS PERFORMED ACCORDING TO AN ANNUAL PLAN BOTH WAREHOUSE SHIPMENTS AND DIRECT SHIPMENTS ARE INCLUDED EXTERNAL LABORATORIES USED FOR THE ANALYSIS (MOST ARE WHO PRE-QUALIFIED) FEW PROBLEMS OBSERVED (MAINLY MARGINALLY LOW ASSAY OR IMPURITIES)

12 TEMPERATURE CONTROL DURING SHIPMENT GDP REQUIREMENT THAT NEEDS TO BE IMPLEMENTED ALL MANUFACTURERS/SUPPLIERS WILL IN THE FUTURE BE REQUESTED TO DOCUMENT CORRECT SHIPMENT CONDITIONS AT SUPPLY TO SUPPLY DIVISION TEMPERATURES DURING DIRECT SHIPMENTS WILL ALSO NEED TO BE MONITORED

13 GMP DEFICIENCIES FROM UNICEF INSPECTIONS QUALITY MANAGEMENT QUALITY RISK MANAGEMENT NOT IMPLEMENTED HANDLING OF CHANGES AND DEVIATION ARE POOR ORGANISATION AND PERSONNEL TRAINING IN PRODUCT RELEASE POORLY DOCUMENTED TRAINING IN ASEPTIC PROCEDURES PRODUCTION CLOTHES SHOULD NOT BE WORN OUTSIDE CONTROLLED AREAS

14 GMP DEFICIENCIES FROM UNICEF INSPECTIONS FACILITIES POOR SEPARATION BETWEEN CONTROL AND NON- CONTROLLED AREAS POOR CONSTRUCTION MATERIALS (DIFFICULT TO MAINTAIN) TOILETS IN PRODUCTION AREAS POOR FLOW OF PERSONNEL FLOW, WHICH PREVENT HANDWASH AT ENTRY TO PRODUCTION AREAS RISK OF CROSS-CONTAMINATION BETWEEN PENICILLINS AND CEPHALOSPORINS DOUBLE STANDARD FACILITIES FOR LOCAL / EXPORT MARKET GENERALLY NOT ACCEPTABLE

15 GMP DEFICIENCIES FROM UNICEF INSPECTIONS EQUIPMENT HVAC NOT DESIGNED TO ENSURE A GOOD AIRFLOW IN THE AREA. AIRFLOW PATTERNS NOT KNOWN. RE-CIRCULATION OF AIR IN NON-STERILE DUSTY AREAS WITHOUT HEPA FILTRATION BOTH IN GENERAL VENTILATION AND IN SPECIFIC EQUIPMENT E.G. FLUID BED DRYERS RISK OF CROSS-CONTAMINATION DUE TO WRONG AIRFLOW DIRECTION PRODUCTION MANUFACTURING PROCESS NOT VALIDATED OR NOT FOR ALL BATCH SIZES

16 GMP DEFICIENCIES FROM UNICEF INSPECTIONS DIFFERENT API SOURCE, THAN THE ONE APPROVED BY UNICEF CONTROL OF API SOURCES AND VENDOR QUALIFICATION IS POOR API SOURCE NOT GMP COMPLIANT HANDLING OF ANALYTICAL WORKING STANDARDS NO FORMAL STABILITY REPORT FOR EACH PRODUCT ANNUAL PRODUCT REVIEW NOT TIMELY CARRIED OUT

17 UNICEF VACCINES Thank you!

Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit

Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND

More information

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality

More information

EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES

EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES Introduction The WHO Prequalification of Medicines Programme (PQP) was established to provide UN

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection Annex 4 Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection 1. Introduction 294 2. Purpose 294 3. Scope 294 4. Assessment tool 295 293 WHO

More information

Guidance for Industry: Starting Material Supplier Management

Guidance for Industry: Starting Material Supplier Management Guidance for Industry: Starting Material Supplier Management Version 1.0 Drug Office Department of Health. Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. Selecting and

More information

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS 1 WHAT IS A SITE MASTER FILE? A Site Master File (SMF) is a document prepared by the manufacturer containing specific

More information

PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING FROM QUALITY DEFECTS

PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING FROM QUALITY DEFECTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 010-4 3 Appendices 1 January 2011 STANDARD OPERATING PROCEDURE PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING

More information

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session 6: WHO Prequalification Programme Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session adapted from the WHO training workshop on prequalification and the WHO technical briefing seminar

More information

Pharmaceutical Wholesaler Site Inspection Checklist

Pharmaceutical Wholesaler Site Inspection Checklist Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

Working with ICH Quality Guidelines - the Canadian Perspective

Working with ICH Quality Guidelines - the Canadian Perspective Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction

More information

Annex 10 Procedure for prequalification of pharmaceutical products

Annex 10 Procedure for prequalification of pharmaceutical products World Health Organization WHO Technical Report Series, No. 961, 2011 Annex 10 Procedure for prequalification of pharmaceutical products 1. Introduction 2. Glossary 3. Purpose and principles 4. Steps of

More information

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1 Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL Site Master File GUIDELINES FOR PREPARATION OF SITE MASTER FILE This document has been prepared as a guide to assist applicants to comply with the requirements for Site Master

More information

gsop-32-02 - Vendor Assessment SOP page 1 of 10

gsop-32-02 - Vendor Assessment SOP page 1 of 10 gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development

More information

Annex 3 Procedure for prequalification of pharmaceutical products

Annex 3 Procedure for prequalification of pharmaceutical products World Health Organization WHO Technical Report Series, No. 953, 2009 Annex 3 Procedure for prequalification of pharmaceutical products 1. Introduction 2. Glossary 3. Purpose and principles 4. Steps of

More information

Annex 9 Guide to good storage practices for pharmaceuticals 1

Annex 9 Guide to good storage practices for pharmaceuticals 1 World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 9 Guide to good storage practices for pharmaceuticals 1 1. Introduction 125 2. Glossary 126 3. Personnel 128 4. Premises and facilities

More information

This guide describes the core components of a SMF suitable for a company holding an importer s or wholesaler s licence.

This guide describes the core components of a SMF suitable for a company holding an importer s or wholesaler s licence. Introduction The purpose of the SMF is to provide the Inspector with an introduction to the company and its activities prior to the commencement of the inspection and to demonstrate to the Inspector that

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

The Quality System for Drugs in Germany

The Quality System for Drugs in Germany The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute

More information

World Health Organization Prequalification of Medicines

World Health Organization Prequalification of Medicines Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections [email protected] 1 WHO GMP In this presentation: Background and Introduction

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products- authorisations, European Medicines Agency Brussels, EudraLex The Rules Governing Medicinal

More information

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

Quality Information. Buchs Manufacturing Site

Quality Information. Buchs Manufacturing Site Buchs Manufacturing Site Related Documents Buchs ISO 9001:2008 Certificate Buchs cgmp Certificate Buchs ISO 13485:2012 Certificate Buchs ISO 17025:2005/ ISO Guide 34 Certificate Buchs Management System

More information

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

Draft guidance for registered pharmacies preparing unlicensed medicines

Draft guidance for registered pharmacies preparing unlicensed medicines Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies

More information

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS June 2006 1 INTRODUCTION Public health concerns demand that the manufacture of pharmaceutical products and their subsequent handling

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control

More information

Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK

Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK Page 1 of 54 Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK Addressee: West African Heath Organization (WAHO), Central

More information

Clinical Trial Logistics

Clinical Trial Logistics Company Brochure Clinical Trial Logistics contents 1. 2. 3. 4. 5. 6. About us Values Facility Quality Management System Services Why PCS Clinical Trial Logistics about us MEET US PHARMA COMPLEX SOLUTIONS

More information

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.

More information

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles World Health Organization WHO Technical Report Series, No. 908, 2003 Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles Introduction 37 General considerations 39 Glossary

More information

Workshop B Control Strategy

Workshop B Control Strategy ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

Nevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8

Nevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8 LABELLING Page 1 of 8 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING HDPE bottle carton label 1. NAME OF THE MEDICINAL PRODUCT Nevirapine

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL

More information

20-21 May 2015, Lisbon, Portugal. Highlights. Speakers:

20-21 May 2015, Lisbon, Portugal. Highlights. Speakers: Speakers: Dr Afshin Hosseiny Chair of the ECA Expert Working Group on GDP, Tabriz Consulting Comply with the new EU GDP Guideline Dr Martin Egger Pharmaserv Dr Daniel Müller GMP/GDP Inspector All participants

More information

Annex 6. Guidance on variations to a prequalified product dossier. Preface

Annex 6. Guidance on variations to a prequalified product dossier. Preface Annex 6 Guidance on variations to a prequalified product dossier Preface This guidance document was technically and structurally inspired by the Guideline on dossier requirements for type IA and IB notifi

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Audit Report in the framework of the APIC Audit Programme

Audit Report in the framework of the APIC Audit Programme Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

What is the correct title of this publication? What is the current status of understanding and implementation?

What is the correct title of this publication? What is the current status of understanding and implementation? GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11 Impact Assessment in a Science & Risk Based Environment R. Legland 11/04/11 Background US GMP s EU GMP s Japan GMP s ICH Q8, Q9, Q10 Guidance ASTM Standard E2500-07 Science and Risk Based Approach to Determine

More information

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

Supplier Quality Assurance

Supplier Quality Assurance Supplier Quality Assurance Preface We strive to continually improve our process performance by meeting quality objectives. It is imperative that our suppliers operate under the zero defects and 100% on

More information

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements Dr. Dirk Feldmann Prof. Dr. Hans-Jörg Müller Aim of the study I.) Comparison of the EU and WHO GMP

More information

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes

More information

Work plan for GMP/GDP Inspectors Working Group for 2016

Work plan for GMP/GDP Inspectors Working Group for 2016 21 December 2015 EMA/INS/GMP/738756/2015 Compliance and Inspection Work plan for GMP/GDP Inspectors Working Group for 2016 Chairperson: Status David Cockburn January 2016 1. Meetings scheduled for 2016

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

Overview of Pre-Approval Inspections

Overview of Pre-Approval Inspections Overview of Pre-Approval Inspections Presented by: Kelli F. Dobilas NWJ-DO Pre-Approval Manager Pre-Approval Drug Inspections What are Pre-Approval Inspections? One of the last reviews of the drug approval

More information

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs. 15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2

More information

GMP Pharma BV. Netherlands

GMP Pharma BV. Netherlands GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization

More information

I N T E R A G E N C Y G U I D E L I N E S. a model quality assurance system for procurement agencies

I N T E R A G E N C Y G U I D E L I N E S. a model quality assurance system for procurement agencies I N T E R A G E N C Y G U I D E L I N E S a model quality assurance system for procurement agencies WHO/PSM/PAR/2007.3 a model quality assurance system for procurement agencies Recommendations for quality

More information

Industry Implications of Pharmaceutical Quality ICH Guidelines

Industry Implications of Pharmaceutical Quality ICH Guidelines EIPG General Assembly Industry Implications of Pharmaceutical Quality ICH Guidelines 20 th April 2008 Pharmaceutical Quality Develop a harmonised pharmaceutical quality system applicable across the lifecycle

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013

WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013 WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013 OUTLINE NIGERIAN PHARMA SECTOR PRINCIPLE OF WHO PREQUALIFICATION PRODUCTS OF INTEREST FOR WHO PQP PROCESS

More information

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division

More information

Quality assurance of pharmaceuticals

Quality assurance of pharmaceuticals QAPPR 12/16/06 12:10 PM Page i Quality assurance of pharmaceuticals A compendium of guidelines and related materials Volume 2, 2nd updated edition Good manufacturing practices and inspection QAPPR 12/16/06

More information

QA for LN Procurement by UNICEF Supply Division

QA for LN Procurement by UNICEF Supply Division UNICEF Supply Division Copenhagen QA for LN Procurement by UNICEF Supply Division Jolanta Wozniak Quality Assurance Centre Agenda The UNICEF Supply Division Model UNICEF QA Introduction Inspections Regulatory

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

Author General Management Quality Assurance

Author General Management Quality Assurance Lab Ofichem B.V. Pag.: 1 / 14 Date: 20-01- Version: 02 Status: geldig Contents 1. General... 2 2. Shared Third Party audit program... 3 3. Reassurance absence of Conflict of Interest... 5 4. Contract structure...

More information

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 In-process control In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 Here you will find answers to the following questions: What are the in-process control tasks? Where

More information

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION 1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information

More information

BRC Food Safety and Quality Management System. New Issue 7

BRC Food Safety and Quality Management System. New Issue 7 New Issue 7 This is an ideal package for Food Manufacturers looking to meet BRC Global Standard for Food Safety (Issue 7 2015) for Food Safety Quality Management Systems. Our BRC Food Safety Quality Management

More information

Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG)

Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG) (H-PIC\S) Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG) The working group of the HPAI ASSIG was chaired by: Aisling Collins BSc (Pharm),

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37. Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION

More information

Community Guide to Good Practice For Feed Additive and Premixture Operators

Community Guide to Good Practice For Feed Additive and Premixture Operators Community Guide to Good Practice For Feed Additive and Premixture Operators INTRODUCTION This European Guide of Practice for Animal Feed Additive and Premixture Operators ( Guide ) responds to the Regulation

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Quality Risk Management

Quality Risk Management PS/INF 1/2010 * * Quality Risk Management Quality Risk Management Implementation of ICH Q9 in the pharmaceutical field an example of methodology from PIC/S Document > Authors: L. Viornery (AFSSAPS) Ph.

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 032-2 8 January 2010 RECOMMENDATION GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE

More information

[NAME OF NATIONAL REGULATORY AUTHORITY] PROCEDURE FOR SUBMISSION CLINICAL TRIAL APPLICATIONS VACCINES AND BIOLOGICALS [COUNTRY]

[NAME OF NATIONAL REGULATORY AUTHORITY] PROCEDURE FOR SUBMISSION CLINICAL TRIAL APPLICATIONS VACCINES AND BIOLOGICALS [COUNTRY] [TEMPLATE] [NAME OF NATIONAL REGULATORY AUTHORITY] PROCEDURE FOR SUBMISSION OF CLINICAL TRIAL APPLICATIONS OF VACCINES AND BIOLOGICALS IN [COUNTRY] 1of 19 General Procedures for clinical trial applications

More information

OVERVIEW OF THE PREQUALIFICATION OF DIAGNOSTICS ASSESSMENT PROCESS. Prequalification of Diagnostics

OVERVIEW OF THE PREQUALIFICATION OF DIAGNOSTICS ASSESSMENT PROCESS. Prequalification of Diagnostics D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF DIAGNOSTICS ASSESSMENT PROCESS Prequalification of Diagnostics PQDx_007 v3 20 April 2010 Table of

More information

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV WHO/VSQ/97.03 Original: English Distribution: General *XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV 3UHSDUHGE\*LOOLDQ&KDORQHU/DUVVRQ3K'*&/%LRFRQVXOW 2WWDZD&DQDGD /LQNWR&RQWHQWVSDJH GLOBAL PROGRAMME

More information

1083.1 QUALITY MANAGEMENT SYSTEM

1083.1 QUALITY MANAGEMENT SYSTEM BRIEFING 1083.1 Quality Management System. USP is proposing a new series of Good Distribution Practices (GDP) general chapters, which were developed as a result of reviewing two existing general chapters,

More information

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System Page 1 of 8 1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System 2. Application This Standard Operating Procedure applied to the entire Quality Management System as it relevant

More information

Canadian Pharmaceutical GMP

Canadian Pharmaceutical GMP Canadian Pharmaceutical GMP Regulations Compared and Contrasted to USFDA GMPs by Richard K. Pike Reference Document Canada The Health Canada revised guidance Document entitled Good Manufacturing Practices

More information

MeriCal Quality Profile

MeriCal Quality Profile January 5, 2015 Dear Valued Customer, Since the implementation of new federal regulations, MeriCal Inc. has received a large volume of questionnaires and surveys regarding our services and procedures.

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

GUIDANCE NOTE 1.1.1 Building Control (Amendment) Regulations 2014 Procurement Implications for Contracting Authorities

GUIDANCE NOTE 1.1.1 Building Control (Amendment) Regulations 2014 Procurement Implications for Contracting Authorities GUIDANCE NOTE 1.1.1 Building Control (Amendment) Regulations 2014 Procurement Implications for Contracting Authorities Office of Government Procurement Building Control (Amendment) Regulations 2014 Procurement

More information

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR WHO/FWC/IVB/QSS/VQR 2011 This guidance document GUIDE TO MASTER FORMULAE is one of a series developed by WHO/FWC/IVB Quality, Safety & Standards team upon request from the manufacturers members of the

More information

INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS

INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS About this document This document is a guide to show what the Inspectorate may look for during an inspection visit. It is intended for use by the GPhC

More information

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Pharmaceutical Affairs Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan 2015 Islamic

More information

GMP/Regulatory Environment in the

GMP/Regulatory Environment in the GMP/Regulatory Environment in the Latin America Irene Ortiz Barreal, Pharm. D., R.Ph. Pfizer International Affiliate Quality Compliance Regional Leader Latin America/Caribbean April 14, 2011 Discloser

More information

Staying Current in Cold Chain Management

Staying Current in Cold Chain Management Staying Current in Cold Chain Management Changes to USP, EU GDPs and Storage and Shipping Practices for Drugs Table of Contents AUTHORS...3 Paul Daniel...3 Piritta Maunu...3 EDITOR...3 John Ferreira...3

More information

Presented by Rosemarie Bell 24 April 2014

Presented by Rosemarie Bell 24 April 2014 Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 contact data Bernd Boedecker Staatliches Gewerbeaufsichtsamt

More information